Search research articles
Contact Us
Filters
Showing results (1-10 of 178) with videos related to
Page
of 18
Sort By:
Journal of Obesity & Metabolic Syndrome
|
January 13, 2026
Response: Toward Precision in Obesity Diagnosis: Progress, Pitfalls, and the Path Ahead (<i>J Obes Metab Syndr</i> 2025;34:85-7)
Chang Hee Jung
Journal of Obesity & Metabolic Syndrome
|
March 3, 2021
Metabolically Healthy Obesity: Is It Really a Benign Condition?
Hwi Seung Kim, Chang Hee Jung
Journal of Obesity & Metabolic Syndrome
|
September 19, 2022
Metabolically Healthy Obesity: Epidemiology, Criteria, and Implications in Chronic Kidney Disease
Yun Kyung Cho, Chang Hee Jung
Endocrinology and Metabolism (Seoul, Korea)
|
April 28, 2016
Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
Yu Mi Kang, Chang Hee Jung
Endocrinology and Metabolism (Seoul, Korea)
|
December 11, 2025
Nutrient-Stimulated Hormone-Based Therapies: Transforming Obesity Management
Ki Hoon Kwak, Chang Hee Jung
Archives of Pharmacal Research
|
January 30, 2013
Molecular mechanisms of central leptin resistance in obesity
Chang Hee Jung, Min-Seon Kim
Journal of Obesity & Metabolic Syndrome
|
April 7, 2025
Toward Precision in Obesity Diagnosis: Progress, Pitfalls, and the Path Ahead
Myung Jin Kim, Chang Hee Jung
International Journal of Molecular Sciences
|
September 28, 2021
Oral Semaglutide, the First Ingestible Glucagon-Like Peptide-1 Receptor Agonist: Could It Be a Magic Bullet for Type 2 Diabetes?
Hwi Seung Kim, Chang Hee Jung
Journal of Obesity & Metabolic Syndrome
|
March 22, 2022
The Upcoming Weekly Tides (Semaglutide vs. Tirzepatide) against Obesity: STEP or SURPASS?
Han Na Jung, Chang Hee Jung
Hepatology International
|
February 5, 2026
Response to letter to the editor "Diagnostic criteria for fatty liver disease: lessons from other diseases"
Yun Kyung Cho, Chang Hee Jung
Page
of 18
Search research articles
Search
Showing results (1-10 of 178) with videos related to
Sort By:
Page
of 18
Journal of Obesity & Metabolic Syndrome
|
January 13, 2026
Response: Toward Precision in Obesity Diagnosis: Progress, Pitfalls, and the Path Ahead (<i>J Obes Metab Syndr</i> 2025;34:85-7)
Chang Hee Jung
Journal of Obesity & Metabolic Syndrome
|
March 3, 2021
Metabolically Healthy Obesity: Is It Really a Benign Condition?
Hwi Seung Kim, Chang Hee Jung
Journal of Obesity & Metabolic Syndrome
|
September 19, 2022
Metabolically Healthy Obesity: Epidemiology, Criteria, and Implications in Chronic Kidney Disease
Yun Kyung Cho, Chang Hee Jung
Endocrinology and Metabolism (Seoul, Korea)
|
April 28, 2016
Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
Yu Mi Kang, Chang Hee Jung
Endocrinology and Metabolism (Seoul, Korea)
|
December 11, 2025
Nutrient-Stimulated Hormone-Based Therapies: Transforming Obesity Management
Ki Hoon Kwak, Chang Hee Jung
Archives of Pharmacal Research
|
January 30, 2013
Molecular mechanisms of central leptin resistance in obesity
Chang Hee Jung, Min-Seon Kim
Journal of Obesity & Metabolic Syndrome
|
April 7, 2025
Toward Precision in Obesity Diagnosis: Progress, Pitfalls, and the Path Ahead
Myung Jin Kim, Chang Hee Jung
International Journal of Molecular Sciences
|
September 28, 2021
Oral Semaglutide, the First Ingestible Glucagon-Like Peptide-1 Receptor Agonist: Could It Be a Magic Bullet for Type 2 Diabetes?
Hwi Seung Kim, Chang Hee Jung
Journal of Obesity & Metabolic Syndrome
|
March 22, 2022
The Upcoming Weekly Tides (Semaglutide vs. Tirzepatide) against Obesity: STEP or SURPASS?
Han Na Jung, Chang Hee Jung
Hepatology International
|
February 5, 2026
Response to letter to the editor "Diagnostic criteria for fatty liver disease: lessons from other diseases"
Yun Kyung Cho, Chang Hee Jung
Page
of 18